These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5128893)

  • 1. Carbamyl phosphate mediated inhibition of the sickling of erythrocytes in whole blood in vitro from sickle cell anemia patients.
    Kraus LM; Kraus AP
    J Lab Clin Med; 1971 Nov; 78(5):843-4. PubMed ID: 5128893
    [No Abstract]   [Full Text] [Related]  

  • 2. Carbamyl phosphate mediated inhibition of the sickling of erythrocytes in vitro.
    Kraus LM; Kraus AP
    Biochem Biophys Res Commun; 1971 Sep; 44(6):1381-7. PubMed ID: 4946263
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the effects of carbamyl phosphate and sodium cyanate on protein synthesis and glutathione concentration in human sickle cell and rabbit reticulocytes.
    Freedman ML; Forte FJ; Roseman J
    J Pharmacol Exp Ther; 1975 Nov; 195(2):340-6. PubMed ID: 1185603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematologic and clinical responses in patients with sickle cell anemia after chronic extracorporeal red cell carbamylation.
    Deiderich DA; Trueworthy RC; Gill P; Cader AM; Larsen WE
    J Clin Invest; 1976 Sep; 58(3):642-53. PubMed ID: 956392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbamyl phosphate modification of hemoglobin S structure resulting in altered sickling.
    Kraus LM; Rasad A; Kraus AP
    Adv Exp Med Biol; 1972; 28():279-96. PubMed ID: 5085172
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation.
    Jensen M; Bunn HF; Halikas G; Kan YW; Nathan DG
    J Clin Invest; 1973 Oct; 52(10):2542-7. PubMed ID: 4729047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of hemoglobin carbamylation on the survival of human sickle cell erythrocytes in rats.
    Castro O; Orlin J; Finch SC
    Yale J Biol Med; 1974 Mar; 47(1):55-60. PubMed ID: 4825087
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydergine and vincamine derivative LD 4298 exhibit no anti-sickling properties in vitro.
    Roth E; Elbaum D; Godoy E; Nagel RL
    Nouv Rev Fr Hematol (1978); 1978; 20(4):611-9. PubMed ID: 752153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of erythrocyte sickling by thiol reagents.
    Garel MC; Domenget C; Galacteros F; Martin-Caburi J; Beuzard Y
    Mol Pharmacol; 1984 Nov; 26(3):559-65. PubMed ID: 6493211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the oxygen affinity and in vitro sickling propensity of carbamylated sickle erythrocytes.
    Diederich D
    Biochem Biophys Res Commun; 1972 Feb; 46(3):1255-61. PubMed ID: 5012168
    [No Abstract]   [Full Text] [Related]  

  • 11. Sickling and Vinblastine.
    Ricci G; Zavagli G
    Biomed Pharmacother; 1983; 37(2):85-7. PubMed ID: 6616035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Morinda lucida Benth. (Rubiaceae) and Newbouldia leavis P. Beauv. (Bignoniaceae) on sickling of red blood cells].
    Joppa KM; Vovor A; Eklu-Gadegbeku K; Agbonon A; Aklikokou K; Gbeassor M
    Med Trop (Mars); 2008 Jun; 68(3):251-6. PubMed ID: 18689316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of carbon dioxide and pH variations in vitro on blood respiratory functions, red blood cell volume, transmembrane pH gradients, and sickling in sickle cell anemia.
    Ueda Y; Bookchin RM
    J Lab Clin Med; 1984 Aug; 104(2):146-59. PubMed ID: 6431043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron deficiency and sickle cell anemia.
    Rao KR; Patel AR; Honig GR; Vida LN; McGinnis PR
    Arch Intern Med; 1983 May; 143(5):1030-2. PubMed ID: 6679216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisickling effects of membrane-interacting compounds.
    Ohnishi ST
    Blood Cells; 1982; 8(2):337-43. PubMed ID: 6130805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
    Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
    Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical and biological aspects of the inhibition of red blood cell sickling by cyanate.
    Manning JM; Cerami A; Gillette PN; De Furia FG; Miller DR
    Adv Exp Med Biol; 1972; 28():253-60. PubMed ID: 5085171
    [No Abstract]   [Full Text] [Related]  

  • 18. An in vitro method for screening compounds for the effect on the rate of sickling of erythrocytes.
    Mackenzie RD; Gleason EM; Schatzman GL; Cawein MJ
    J Int Med Res; 1976; 4(6):375-81. PubMed ID: 1027632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of pH on the rheologic and antisickling effects of dimethyl adipimidate.
    Pennathur-Das R; Lande WM; Mentzer WC; Mohandas N; Preisler H; Kleman KM; Heath RH; Lubin BH
    J Lab Clin Med; 1984 Nov; 104(5):718-29. PubMed ID: 6491469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sickling in vitro of reticulocytes from patients with sickle cell disease at venous oxygen tension.
    Horiuchi K; Onyike AE; Osterhout ML
    Exp Hematol; 1996 Jan; 24(1):68-76. PubMed ID: 8536795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.